Regulations.gov document
Microbiology Devices; Reclassification of Cytomegalovirus Doxyribonucleic Acid…
Proposed Rule · FDA-2016-N-2880 · posted Sep 18, 2020
Key facts
| Document ID | FDA-2016-N-2880-0004 |
|---|---|
| Title | Microbiology Devices; Reclassification of Cytomegalovirus Doxyribonucleic Acid Quantitative Assay Devices Intended for Transplant Patient Management, To Be Renamed Quantitative Cytomegalovirus Nucleic Acid Tests for Transplant Patient Management |
| Document type | Proposed Rule |
| Subtype | Request for Comment |
| Agency | FDA |
| Docket | FDA-2016-N-2880 |
| Posted | Sep 18, 2020 |
| Federal Register citation | 85 FR 58300 |
| FR document number | 2020-20716 |
| CFR | 21 CFR Part 866 |
| Comment period opens | Sep 18, 2020 |
| Comments due | Nov 18, 2020 |
| Effective date | Sep 18, 2020 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: